Archived documents

Documents past their public comment period for Healthcare & Public Health.

FDAOther

PSG_212888 - Draft Guidance on Cabotegravir; Rilpivirine

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →Closes Jul 22
FDAOther

PSG_219921 - Draft Guidance on Carboplatin

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →Closes Jul 22
FDAOther

PSG_050406 - Draft Guidance on Cephalexin

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →Closes Jul 22
FDAOther

PSG_021658 - Draft Guidance on Ciclesonide

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →Closes Jul 22
FDAOther

PSG_050767 - Draft Guidance on Clindamycin Phosphate

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →Closes Jul 22
FDAOther

PSG_213491 - Draft Guidance on Cysteamine Bitartrate

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →Closes Jul 22
FDAOther

PSG_203389 - Draft Guidance on Cysteamine Bitartrate

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →Closes Jul 22
FDAOther

PSG_020392 - Draft Guidance on Cysteamine Bitartrate

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →Closes Jul 22
FDAOther

PSG_211379 - Draft Guidance on Dexamethasone

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →Closes Jul 22
FDAOther

PSG_208742 - Draft Guidance on Dexamethasone

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →Closes Jul 22
FDAOther

PSG_022122 - Draft Guidance on Diclofenac Sodium

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →Closes Jul 22
FDAOther

PSG_219876 - Draft Guidance on Dordaviprone Hydrochloride

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →Closes Jul 22